Overall, the supplement is valued for its quality, effectiveness in promoting gut health, and contribution to weight management goals
This is mainly because of the reported weight loss While GLP-1 medications Zepbound and This rapid increase in users of GLP-1 drugs has caused Now, a new study published in Annals of Internal Medicine , reports that among the approximately 1 million new GLP-1 medication users identified between 2011 to 2023, there was a twofold increase in GLP-1 medication users who do not have type 2 diabetes but do have a body mass index (BMI) of 30 killograms per square meter (kg/m 2 ) or greater, and in people with a BMI of 27 to 30 kg/m 2 and an obesity-related The researchers also found that the proportion of users of GLP-1 medications without FDA-approved indications rose from 0.21% in 2019 to 0.37% in 2023
S., Gelfanov, V., Lindsey, S
See how voice AI is bridging that gap for patients synthiolabs.com #PatientSupport #PharmaCommercial #LifeSciences #Adherence #AIinPharma #SynthioLabs To view or add a comment, sign in More than half of new specialty drug prescriptions never reach the patient Timely by DrFirst launched a provider solution designed to fix patient access problems at the source: the point of prescribing
Patients experiencing nausea may benefit from eating smaller, more frequent meals rather than large portions, as the medication already slows stomach emptying